Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 4800  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page


 
Table of Contents 
CORRESPONDENCE
Year : 2020  |  Volume : 65  |  Issue : 3  |  Page : 228-229
Metabolic syndrome and dyslipidemia among Nigerians with lichen planus: A cross-sectional study - Reader's question


Professor in Pediatrics and Child Health, Consultant Pediatrician, Department of Pediatrics, Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq

Date of Web Publication14-Apr-2020

Correspondence Address:
Mahmood D Al-Mendalawi
Professor in Pediatrics and Child Health, Consultant Pediatrician, Department of Pediatrics, Al-Kindy College of Medicine, University of Baghdad, Baghdad
Iraq
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijd.IJD_447_19

Rights and Permissions



How to cite this article:
Al-Mendalawi MD. Metabolic syndrome and dyslipidemia among Nigerians with lichen planus: A cross-sectional study - Reader's question. Indian J Dermatol 2020;65:228-9

How to cite this URL:
Al-Mendalawi MD. Metabolic syndrome and dyslipidemia among Nigerians with lichen planus: A cross-sectional study - Reader's question. Indian J Dermatol [serial online] 2020 [cited 2020 Sep 20];65:228-9. Available from: http://www.e-ijd.org/text.asp?2020/65/3/228/282461




Sir,

I read the interesting case–control study by Okpala et al.[1] published in the July–August 2019 issue of the Indian Journal of Dermatology. The authors studied the prevalence of metabolic syndrome (MetS), dyslipidemia, and associated factors in a cohort of Nigerian patients with lichen planus (LP). They found an insignificantly increased MetS prevalence in LP patients compared with controls. However, dyslipidemia was associated significantly with LP. The family history of diabetes mellitus was an independent predictor of MetS in the LP patients. Patients with LP demonstrated a significantly higher serum level of low-density lipoprotein cholesterol, total cholesterol and triglyceride than controls.[1] The authors recommended that LP patients must be routinely screened for MetS and its components.[1] The authors mentioned one study limitation as the availability of fund was a significant factor that limited the sample size to the minimum. I assume that the following methodological limitation might additionally cast suspicions on the accuracy of the study results and recommendation. In the study methodology, the authors stated that MetS and dyslipidemia were diagnosed using the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria.[1] It is explicit that there are many MetS definition criteria, notably International Diabetes Federation (IDF), American Association of Clinical Endocrinologists (AACE), World Health Organization (WHO), Revised National Cholesterol Education Program (NCEP-R), and NCEP-ATP III criteria. Importantly, NCEP-ATP III criteria employed by Okpala et al.[1] is currently no more worthy because it was introduced more than a decade ago.[2] Moreover, the evaluation of the aforementioned MetS criteria in Nigeria revealed that the level of agreement among these criteria appeared to be generally poor.[3] As many population-specific MetS criteria have been constructed,[4],[5] I assume that the formulation of the national Nigerian MetS criteria could better estimate MetS prevalence and define associated factors in LP patients. Despite the study limitations, LP patients need to undergo regular follow-up for efficient cardiovascular disease prevention.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Okpala IC, Akinboro AO, Ezejoifor IO, Onunu AN, Okwara BU. Metabolic syndrome and dyslipidemia among Nigerians with lichen planus: A cross-sectional study. Indian J Dermatol 2019;64:303-10.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American heart association/National heart, lung, and blood institute scientific statement. Circulation 2005;112:2735-52.  Back to cited text no. 2
    
3.
Onesi SO, Ignatius UE. Metabolic syndrome: Performance of five different diagnostic criteria. Indian J Endocrinol Metab 2014;18:496-501.  Back to cited text no. 3
    
4.
Ding Z, Pi F, Zhang S, Dong W, Wen Y, Wu J, et al. Establishment and application of a new diagnostic definition of metabolic syndrome in the Shantou region of southern China. Sci Rep 2016;6:22210.  Back to cited text no. 4
    
5.
Yamagishi K, Iso H. The criteria for metabolic syndrome and the national health screening and education system in Japan. Epidemiol Health 2017;39:e2017003.  Back to cited text no. 5
    




 

Top
Print this article  Email this article
 
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (259 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed344    
    Printed6    
    Emailed0    
    PDF Downloaded18    
    Comments [Add]    

Recommend this journal